(Q38162892)

30 August 2017

title

Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective (English)

1 reference

30 August 2017

0 references

1 reference

Robert J Stratta

1

1 reference

30 August 2017

Alan C Farney

series ordinal

2

1 reference

30 August 2017

Jeffrey Rogers

series ordinal

3

1 reference

30 August 2017

Giuseppe Orlando

series ordinal

4

1 reference

30 August 2017

publication date

1 January 2014

1 reference

Expert Review of Clinical Immunology

30 August 2017

published in

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

117-132

1 reference

Immunological monitoring after pancreas transplantation

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

President's Address. The Transplantation Society--Berlin 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

OPTN/SRTR 2011 Annual Data Report: pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Immunosuppressive standards in simultaneous kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Novel immunosuppression in pancreas transplantation and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Advances in immunosuppression for pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Minimization and withdrawal of steroids in pancreas and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Minimization protocols in pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Immunosuppression in simultaneous pancreas-kidney transplantation: progress to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Trends in immunosuppression after pancreas transplantation: what is in the pipeline?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Induction therapy in pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Rejection after simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Prevention and management of hyperglycemia after pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Recurrence of autoimmunity following pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Excellent Short-term Results With Steroid-Free Maintenance Immunosuppression in Low-Risk Simultaneous Pancreas-Kidney Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Very early steroid withdrawal in simultaneous pancreas-kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Single-shot antithymocyte globuline and daclizumab induction in simultaneous pancreas and kidney transplant recipient: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Distinctive morphological features of antibody-mediated and T-cell-mediated acute rejection in pancreas allograft biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

Pancreas transplantation, antibodies and rejection: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.853616

10.1586/1744666X.2014.853616

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference